The Vaccine and Gene Therapy Institute at Oregon Health & Science University has assembled a multidisciplinary team of scientists to respond to serious viral disease threats, including AIDS, chronic viral infection-associated diseases, newly emerging viral diseases and infectious diseases of the elderly. Our programs are intended to span the continuum between basic and clinical science, in which discoveries are rapidly advanced from the level of molecular and cellular biology through animal models and ultimately into clinical testing. Learn more
Seminars are canceled until further notice.
PLoS Pathog. March 12, 2020
The human IL-15 superagonist N-803 promotes migration of virus-specific CD8+ T and NK cells to B cell follicles but does not reverse latency in ART-suppressed, SHIV-infected macaques
J Immunol. March 11, 2020
MHC-E-Restricted CD8+ T cells target hepatitis B virus-infected human hepatocytes
Nat Immunol. February 17, 2020
HIV-1-induced cytokines deplete homeostatic innate lymphoid cells and expand TCF7-dependent memory NK cells
Front Microbiol. February 14, 2020
The E3 ubiquitin ligase SIAH1 targets MyD88 for proteasomal degradation during Dengue Virus infection
Your gifts help provide vital resources to conduct innovative research and more.